Monthly Archives: February 2022

Man Drugs His Father’s Tea to Steal $400,000 in Crypto – Futurism

Posted: February 11, 2022 at 6:29 am

"It didnt have to be like this!"The Tea

A 24-year-old man from Bethesda, Maryland took extreme measures to get his hands on his fathers cryptocurrency holdings,which were worth $400,000 at the time.

In a shocking fit of desperation, Liam Ghershony, who was struggling with drug abuse at the time, decided to poison his father with depressants so he could gain access to daddys funds via his cellphone, The Washington Post reports.

Its a grim story that shows drug abuse and obsessing over cryptocurrencies can create a lethal mix. In fact, a number of rehab clinics are starting to offer addicts a way to control their obsession with cryptocurrencies specifically.

It didnt have to be like this! Ghershony wrote in a note he left behind, according to WaPo, after dosing his fathers tea with a benzodiazepine, a class of drugs related to tranquilizers and Xanax. Im gonna give you the best retirement.

Fortunately, first responders found his father collapsed on the floor two days later. He later recovered after a four-day stint in the hospital.

The junior Ghershony and his father were able to cash in $350,000 after tax through a crypto investment account back in 2018. But his problematic use of drugs started to take off afterward.

While ingesting copious amounts of benzodiazepines, Adderrall, and cocaine, Ghershony started to become increasingly paranoid about the joint crypto holdings. His father recalled to WaPothat Ghershony used to tell him that he needed to sell.

The 24-year-old realized far too late that his own tolerance to benzos was a whole lot higher than his fathers. He was only aiming to knock his father out to sleep not to hospitalize him, he later told the Post.

Ghershony, who had no prior criminal record, pleaded guilty to a first-degree assault charge after reaching an agreement. He spent 125 days in jail, according to the newspaper, and two subsequent months in drug and mental health rehab.

READ MORE: He spiked his fathers tea to access $400,000 in cryptocurrency. His dad awoke two days later. [The Washington Post]

More on cryptocurrencies: Facebook Is Reportedly Trying to Sell Off Its Botched Cryptocurrency

Care about supporting clean energy adoption? Find out how much money (and planet!) you could save by switching to solar power at UnderstandSolar.com. By signing up through this link, Futurism.com may receive a small commission.

Excerpt from:
Man Drugs His Father's Tea to Steal $400,000 in Crypto - Futurism

Posted in Futurism | Comments Off on Man Drugs His Father’s Tea to Steal $400,000 in Crypto – Futurism

Mark Zuckerberg Reportedly Had Red Eyes and a Weird Excuse at Company-Wide Meeting – Futurism

Posted: at 6:29 am

Uh, what's going on, Mark?Meta-Terse

During a pivotal post-stock selloff meeting, Meta CEO Mark Zuckerberg gave a very bizarre reason for looking like he was,well, about to cry on camera.

AsBloombergreports, a red-eyed Zuckerberg told employees on a company-wide video meeting responding to the companys huge stock drop that if he began crying, it was because hed scratched his cornea.

The strange claim, which may or may not have been an attempt at humor, came amid a historic drop in the companys stock value, which lost a quarter of its value this week due to both a shrinking userbase and a giant projected loss of revenue, prompting investors to sell off their holdings en mass.

Indeed, the current situation at the company formerly known as Facebook seems quite grim with the Meta stock dropping more than $250 billion or 26.4 percent in market value, which is the greatest loss the company has ever seen and the greatest single-day dive in the history of the stock market to boot.

In the face of it all, Zuckerberg implored his employees during the meeting to focus more energy on Instagram Reels to try to respond to the unprecedented level of competition posed by TikTok,Bloomberg reports per an anonymous source.

Facebook has, of course, tried and spectacularly failed to pivot to video before, and its tempting to analyze this advice from Zuckerberg as an attempt to lay blame not on the CEOs poor business decisions but instead on the people who work for him.

Those same employees are often compensated with stock options, so the quarter drop in Metas stock and the massive sell-off could lead to valuable employees leaving the company, another anonymous source toldBloomberg.

Zuckerberg himself also experienced a net worth loss of an eye-reddening $31 billion, theBBC reports though given that hes still one of the worlds richest men and worth a cool $90 billion after the drop, the situation is a lot more dire for his employees than for him personally.

We wont know exactly how bad this is for Facebook or its nascent Metaverse is until the dust settles, but given how much energy and money Zuckerbergs put into this moonshot, lets just say the optics arent great.

READ MORE: Zuckerberg Tells Staff to Focus on Video Products as Metas Stock Plunges [Bloomberg]

More on Meta:Facebooks Top VR Expert Seems Pretty Annoyed by Metaverse Push

Care about supporting clean energy adoption? Find out how much money (and planet!) you could save by switching to solar power at UnderstandSolar.com. By signing up through this link, Futurism.com may receive a small commission.

The rest is here:
Mark Zuckerberg Reportedly Had Red Eyes and a Weird Excuse at Company-Wide Meeting - Futurism

Posted in Futurism | Comments Off on Mark Zuckerberg Reportedly Had Red Eyes and a Weird Excuse at Company-Wide Meeting – Futurism

Nintendo Switch OLED Review: A Must-Have for Gamers on the Go – Futurism

Posted: at 6:29 am

No matter how great a new Nintendo console is, the first iteration can almost always be considered a beta. Upon its first release, the Game Boy Advance still ran on batteries and didnt even have a backlight. The bulky original Nintendo DS looks practically primitive when compared to the far sleeker Nintendo DS Lite. Early adopters help Nintendo in working out the kinks before a shinier option makes this years model obsolete. This brings us to the Nintendo Switch OLED model.

The third iteration of Nintendos immensely popular home console is the latest upgrade offered after the basic models release in 2017, followed by the Nintendo Switch Mini in 2019. There are a few technical enhancements but the obvious one is its big, bright OLED screen. Is this new display worth shelling out the extra gold coins for, or should gamers hold out until the next revamp? It depends on how you get your game on, of course.

Specifications: Released: October 8, 2021 Dimensions: 4 inches H x 9.5 inches L x 0.55 inches D, with Joy-Cons attached Weight: 14.88 ounces, with Joy-Cons attached Screen: 7-inch Multi-touch capacitive OLED GPU: Nvidia Custom Tegra processor Storage: 6GB, upgradeable up to 2TB with microSD cards, sold separately Wireless: WiFi (IEEE 802.11 a/b/g/n/ac compliant)/Bluetooth 4.1 Video Output: Up to 1080p via HDMI in TV mode, Up to 720p via the built-in screen in tabletop and handheld modes Audio Output: Compatible with 5.1ch Linear PCM output, Output via HDMI connector in TV mode. Stereo speakers, 3.5mm 4-pole stereo headphone jack Sensor: Accelerometer, gyroscope, and brightness sensors Battery: Lithium-ion battery / 4310mAh Inputs: 2 USB 2.0, Wired LAN Battery Life: Runs from 4.5-9 hours, depending on settings and game Charging Time: 3 hours

The original Nintendo Switch was released in March of 2017, and since then, rumors swirled of a Nintendo Switch Pro. In July of 2021, Nintendo unveiled the third version of its hybrid portable/home console with Nintendo Switch OLED. It wasnt the technical powerhouse fans expected, but it did sport a handful of upgrades. The obvious one is the big and very bright 7-inch OLED screen. Comparably, the original Nintendo Switch screen is a simpler 6.2-inch IPS (a simpler, less-bright LED style) display.

Nintendo Switch OLEDs new stand spans the length of the back of the console and is a little sturdier when playing in tabletop mode. Its also adjustable, so you can view the console from a handful of different angles. Nintendo Switch OLEDs dock comes with a built-in Ethernet port for more secure wired connections, but it did so at the cost of one of the USB 2.0 ports. Strangely enough, both the original Nintendo Switch and the OLED upgrade work with this new dock.

Aside from the obvious screen which gives this new model its name, there are a few new changes to the console. For one, Nintendo Switch OLED comes with a whopping 64 GB of memory, which doubles the space available on the original Nintendo Switch. Its a welcome addition to anyone whos determined to go digital this generation. The consoles memory is upgradable up to 2TB via a microSD card, which slides into the console just under its stand.

Related: Best Nintendo Switch Controllers

Anytime a new version of a console is released, a dedicated user must ask themselves a question: Do I need to drop the cash on this new version? After all, the previous new Nintendo Switch offering was rather easy to pass on. Nintendo Switch Lite is built strictly for portability, is a good bit smaller, and doesnt even come with a dock to connect it to a television. But is it worth upgrading to the OLED model? Heres a peek at my first four months with the Nintendo Switch OLED.

Nintendo Switch OLED was released on October 8, 2021, alongside the celebrated and long-awaited Metroid: Dread. Samus latest romp was a perfect pairing with this new console. The game includes some spooky stealth areas where blood-thirsty AI robots chase you down narrow passages. If they get their metal mitts on you, they run a spike through your neck causing an instant Game Over that fills the player with visceral dread, hence the name. To amplify this heart-pumping action, I played Dread with all the lights off in the house, save for the light coming from the screen, which admittedly was abundant. After about an hour of play, it was clear that there was no going back to playing in handheld mode on a lesser Switch console.

For a console that doubles as a portable, giving the device an OLED screen was an easy way to bolster the visual output of the Switch OLED, which lags behind the Xbox Series X and the PS5. Both the Microsoft and Sony consoles output in 4-8K, and even have processing powers that can go toe to toe with modern gaming PCs. OLED stands for Organic Light Emitting Diode, and these screens are put in everything from smartphones to cameras. The technology provides brighter screens, better contrast, wider color ranges, and even faster refresh rates, which makes them perfect for gaming applications. Its no surprise that my experience with Metroid: Dread felt all the more terrifying considering that everything including the wall-crawling death robots looked crisper than ever before. Releasing Metroid: Dread along with the new console was a seriously smart way to show off the Nintendo Switch OLEDs capabilities.

A new screen gives gamers a good excuse to dip back into games that were released ages ago, including visual masterpieces like The Legend of Zelda: Breath of the Wild and Super Mario Odyssey. While big-screen experiences are engrossing, unless your television is also an OLED TV, playing in handheld mode is almost always preferable. Light is such a game-changer when it comes to portable gaming. Even playing legacy titles via Nintendo Switch Online feels new and more immersive than before. Even in 16-bit titles, colors come in more vibrant than before. Kirby pinks, Pikachu yellows, and of course, Mario reds practically pop off the screen.

While the screen is the Nintendo Switch OLEDs main improvement, there are a few more QoL upgrades. The new Nintendo Switch OLED stand spans the length of the back of the screen and offers far more angles than the original ever did. I can say with confidence that Ive never played in tabletop mode. However, a handful of multiplayer titles could take advantage of this, including Nintendo Switch versions of popular board games like Monopoly Madness and Catan.

The Nintendo Switch OLED dock also comes with a wired LAN port. I wish I could report that this vastly improves the lackluster Nintendo Switch Online multiplayer experience. Sadly, it does not. While the dock traded one of its USB 2.0 ports for it, this sacrifice isnt one that stung too much. The inside of the dock is a little crowded, so most USB accessories had a hard time maneuvering back there anyway. And thats all she wrote, upgrades-wise. Nintendo touts better speakers in tabletop and handheld modes, but the difference between the Nintendo Switch OLED and the original model is negligible. The battery life, video output, and GPU remain unchanged. That fabled Nintendo Switch Pro with all the technical upgrades is nothing but a dreamfor now.

Q: Where can I buy Nintendo Switch OLED?You can buy the Nintendo Switch OLED in most stores where video games are sold.

Q: When will Nintendo Switch OLED be back in stock?When will the Nintendo Switch OLED be back in stock? Nintendo Switch OLED stock always moves fast, but its available on Walmart.com.

Q: Does the Nintendo Switch have an OLED screen?The newest Nintendo Switch OLED contains an OLED screen. The original Nintendo Switch and Nintendo Switch Lite contain LCD screens.

For gamers looking for a console powerhouse with 4K output and faster processing speeds, the Nintendo Switch OLED feels like a smack in the face. Granted, lagging behind the competition is what Nintendo does best, and its a gamble that often pays off, especially in the current console generation. The Switch OLED packs a beautiful screen that makes experiences in new games more memorable and immersive than ever before when playing in handheld and tabletop mode. If your Switch never hardly ever leaves your dock, theres no sense in upgrading just yet. However, if youre the kind who games on the couch, in bed, in the car, and yes, even in the bathroom, the Nintendo Switch OLED may be a worthy investment for your gaming habit. This goes double for the few who have yet to dive into the Nintendo Switch craze. Theres no better place to start than with the Nintendo Switch OLED.

This post was created by a non-news editorial team at Recurrent Media, Futurisms owner. Futurism may receive a portion of sales on products linked within this post.

Care about supporting clean energy adoption? Find out how much money (and planet!) you could save by switching to solar power at UnderstandSolar.com. By signing up through this link, Futurism.com may receive a small commission.

Read this article:
Nintendo Switch OLED Review: A Must-Have for Gamers on the Go - Futurism

Posted in Futurism | Comments Off on Nintendo Switch OLED Review: A Must-Have for Gamers on the Go – Futurism

Surprise! Companies That Promised to Hit Net-Zero Emissions Are Failing Miserably – Futurism

Posted: at 6:29 am

"We were frankly surprised and disappointed at the overall integrity of the companies claims."Damning Report

In an incredibly predictable turn of events, a new study found that large corporations that promised to fight climate change are doing a laughably bad job at it.

The NewClimate Institute, an environmental advocacy group, released a report that looked at the climate plans of 25 corporations that promised to cut their emissions down to net zero. It found that the companies plans to reach that target would reduce emissions by roughly 40 percent on average by 2030 falling far short of net zero.

We set out to uncover as many replicable good practices as possible, but we were frankly surprised and disappointed at the overall integrity of the companies claims, Thomas Day, climate policy analyst at NewClimate Institute lead author of the study, said in a press release.

The report also analyzed each company by integrity, comparing what each said it would do and what its actually doing in terms of fighting climate change.

None of the companies with net zero pledges scored the top high integrity ranking. Just one company shipping company Maersk had its second-tier reasonable integrity ranking. Many other large corporations such as Amazon, Google, and Walmart had low integrity.

As pressure on companies to act on climate change rises, their ambitious-sounding headline claims all too often lack real substance, which can mislead both consumers and the regulators that are core to guiding their strategic direction, Day said. Even companies that are doing relatively well exaggerate their actions.

The report just underscores the need for the worlds largest corporations and the biggest contributors to anthropogenic climate change to do more to reduce carbon emissions. Virtue signaling simply isnt enough. Real action needs to occur.

READ MORE: Major companies largely fail net zero climate pledge test [NewClimate Institute]

More on climate change: Climate Change Air Conditioning Spike Will Cause Widespread Blackouts, Scientists Warn

Care about supporting clean energy adoption? Find out how much money (and planet!) you could save by switching to solar power at UnderstandSolar.com. By signing up through this link, Futurism.com may receive a small commission.

Here is the original post:
Surprise! Companies That Promised to Hit Net-Zero Emissions Are Failing Miserably - Futurism

Posted in Futurism | Comments Off on Surprise! Companies That Promised to Hit Net-Zero Emissions Are Failing Miserably – Futurism

D. Lopez, This Week in the Garden | Flowers that wear blue genes – Santa Cruz Sentinel

Posted: at 6:28 am

Roses are red, violets are bluebut people want blueroses! In the industry offloriculture, the cut blue floweris a coveted product. So muchso, that according to theInstitute of of Vegetable andFloriculture Science,ornamental flowers such asroses and chrysanthemumshave been the target ofbreeding blue varieties. Thedemand for blue flowers inplant varieties missing the blue gene is high, however thisrequires genetic engineering.

Blue flowers are used symbolically to express mystery or attaining the impossible. Literature suggests this, dating back to the 12th century Arab writings. The reference to azure roses was due to the practice of exposing the bark of roots to blue dye.

Even after many attempts at bioengineering, a rose that contains the blue delphinidin-based pigments does not exist naturally. At best, both an Australian and Japanese company created a lilac and mauve rose, in attempts to achieve the impossible blue rose. However, if you would like a blue chrysanthemum, they exist, thanks to the bioengineering of Japanese scientists. How this is done is quite an effort.

Bioengineering. This is what I asked about cultivars or a genetically modified organisms, what is the technical difference? Cultivars are created by seed control or grafting while genetic modification is a multistep process by specifically transferring missing genes to an organism.

The blue pigment gene is oddly a challenge to both creating blue cultivars or blue genetically modified flowers. Therefore, all blue flowers are extra special. Of course, there are many natural varieties.

More importantly, natural blue flowers are said to have an interesting role with pollinators. According to Newfoundland and Labrador University Botanical Garden, different colors attract different pollinators. For example, bees are mostly attracted to blues and purples, but not so with reds. Science News states that blue flowers create a higher volume of nectar. Also, blue-violet flowers have nano particles on their petals, scattering UV light, creating a halo effect, and is very attractive to bees. The stronger the blue, the more attractive the flower. Even if it is simply a blue stripe on the petals.

Fortunately, there are numerous blue flowers that need no modification. The most charming wildflower I grew last summer was the California Bluebell, Phacelia campanularia. The California bluebell grows easily from seed with no special soil requirements. Then there is Baby Blue Eyes, Nemophila menziesii, a dainty annual blue flower that grows throughout wild places in California. Seeds are available by many heirloom seed companies. California Lilac, Ceanothus, is a hardy perennial andnitrogen-fixing shrub in the buckthorn family. The California Lilac is not a true lilac; I imagine its tiny fragrant flower clusters is attributed to this name, having much less a lilac color, but more of a blue-violet. In the fall I planted several varieties of lupine. Sky Lupine, Lupinus nanus, will offer you striking blue stalks in a small shrub, and are nitrogen fixers. Another suggestion is Whirly Blue Sage. Whirly Blue Sage is a hybrid of Salvia clevelandii and s.leucophylla, an aromatic grey-green shrub with strongly colored tufts of flowers along its 1-2 foot blooming stalks.

Hopefully, you are not expecting blue roses for the next celebration or romantic gesture. As of yet, it is not attainable. However, if you want a colorful wildflower garden that also supports the bee population, now is the time to do a seed scattering. Give it a try in those difficult to grow places. As an example, California wildflowers are preparing to burst on the hillsides along the highways of your next road-trip. This inspiring springtime event gives us direction of how effortless seed distribution can be.

If there is a more pressing landscape need, then consider the majestic native shrubs like lupines or sages. Our little winged friends will be keeping an eye out for these blue beauties this year. Enjoy a new season of gardening.

Read the original:
D. Lopez, This Week in the Garden | Flowers that wear blue genes - Santa Cruz Sentinel

Posted in Genetic Engineering | Comments Off on D. Lopez, This Week in the Garden | Flowers that wear blue genes – Santa Cruz Sentinel

Bayer Takes a Leap for Off-the-Shelf NK Cell Therapy – BioSpace

Posted: at 6:28 am

Bayers investment arm is taking another leap for cell therapies, joining in the$50 millionSeries A for San Franciscos Indapta Therapeutics.

Like many current immunotherapy-focused biotechs, Indapta is harnessing the power of the bodys natural killer (NK) cells to fight cancerous intruders. This biotech is focused on a subset of NK cells, the G-NK cells, to create an off-the-shelf therapeutic donated from healthy donors without any need for genetic engineering.

G-NKL cells have increased potency when compared to conventional natural killers. Indapta has found them particularly potent when combined with a monoclonal antibody (mAb) treatment. When the mAb binds to the tumor target and the G-NK cell, the cancer-killing compounds released are dramatically increased.

Indaptas G-NK cell therapies do better and last longer in storage through specific selection and proprietary manufacturing, making them available and more ready to use.

While last years dreams had the company on track to begin trials in 2021, reality has them gearing up for the task in 2022. The proceeds from this Series A will fuel the advancement of Indaptas allogeneic NK cell platform toward a New Drug Application and into clinical trials.

The golden state company is also expanding the team to tackle this newest challenge, bringing in a new CEO to hopefully take its promising platform to market. Taking the helm from the founding CEO, Guy DiPierro, who will now become chief strategy officer, is Dr. Mark Frohlich, M.D.

Frohlich has a vast resume in the oncology immunotherapies world. While the last few years have found him consulting and serving on boards for oncology biotech companies, he was in the C-suite at Juno Therapeutics as EVP of portfolio strategy. Juno developed Breyanzi to fight large B-cell lymphoma. The company was then bought up, and Bristol-Myers Squibb brought the drug through approval to commercialization last year.

Hes had his hand in bringing one of the first cancer immunotherapies to the market as CMO and EVP at Dendreon. In the early 2000s, Frohlich led the clinical team responsible for development and approval.

Mark is perfectly suited to lead Indapta as we move our unique G-NK cell therapy closer to clinical trials in patients with multiple myeloma and lymphoma, said Ronald Martell, co-founder and chairman of the board.

This round was co-led by RA Capital Management, LP, Vertex Ventures and Leaps by Bayer. Leaps has been dropping dollars into quite a few companies the last few weeks. A Vancouver startup combining the power of cryo-electron microscopy with AIsnagged$40 million in its Series A led by Leaps. The previous week, two cell therapy companies caught the investment teams eye forgene editing programsandAI-powered cell therapies.

Read the original:
Bayer Takes a Leap for Off-the-Shelf NK Cell Therapy - BioSpace

Posted in Genetic Engineering | Comments Off on Bayer Takes a Leap for Off-the-Shelf NK Cell Therapy – BioSpace

Digital health is making healthcare more open, inclusive and patient-centred – World Economic Forum

Posted: at 6:28 am

Over the last two decades, data and digital technologies have begun to converge with medicines, devices, and diagnostics to create a new market for digital health. The Covid-19 pandemic has accelerated demand for connected drug delivery and wearable devices and apps for remote monitoring, patient engagement and adherence.

With instant access to a vast amount of healthcare information, tremendous opportunities exist to detect disease earlier, hasten the development of new treatments, and personalize them to individual patients.

Connections between people, machines and data are set to further strengthen over the next decade thanks to advances in genetic engineering, next-generation semiconductors, machine learning and human-machine interfaces like biosensors and augmentation.

Similarly, AI, IoT and machine-to-machine communications will help organizations make their clinical development and supply chain processes faster and more efficient.

This surge in data accumulation and processing power represents a transformational opportunity for patient care to become more precise, predictive, personalized, and convenient.

Over the last decade, however, healthcare information has remained largely siloed away in unstructured networks and closed ecosystems. Such closed, unconnected environments not only reduce opportunities to derive synergistic benefits across the value chain. They also harm levels of patient trust and engagement.

A survey by McKinsey of digital heath stakeholders found that success requires an integrated approach that delivers convenience and impact across the patient journey. This survey, as well another recently published by Imperial College London, identified that for data-driven healthcare to succeed, it must be built upon a platform of trust. However, most American and European patients remain unwilling to share their medical data with authorized healthcare stakeholders especially those from the private sector.

The full potential of digital health can only be realized with an open, ethical, inclusive approach where stakeholders work together in the best interests of patients.

Developing secure, transparent, and integrated ecosystems require collaboration. Syntropy, a partnership between Merck and software leader, Palantir, is one such effort.

This separate entity is helping organizations unlock the potential of their health data to accelerate research and clinical outcomes that advance patient care. Importantly, Syntropy never takes ownership of the data and always transparently attributes its origin. With this framework, Syntropy is working with a range of companies, hospital networks, and research institutes to develop AI-enabled ecosystems for cancer and other therapeutic areas that solve research problems in real-time.

Merck has established a Code of Digital Ethics (CoDE) to cement strong ethics around its digital health activities, a first for a large company in the healthcare industry. The CoDE, based on a decades worth of digital ethics learnings, governs how Merck approaches all activities relating to the development, commercialization and use of digital products and processes.

The core principles of the CoDE are autonomy, justice, beneficence, non-maleficence, and transparency. These principles ensure Merck operates in a safe, transparent, and accountable manner that benefits patients, the healthcare sector, and society at large. Other healthcare companies should consider establishing CoDEs that complement these guiding ethical principles.

Regulatory guidelines and spirited outreach efforts are already helping achieve better ethnic and gender diversity in clinical trials. However, to truly achieve health equity, an even more inclusive approach is required. We must reduce access lag and enable precision pharmacotherapy for all patients.

Our industry today has an opportunity to build on recent breakthroughs in understanding the human genome and modern sequencing technologies to create a universal molecular signature of human diversity.

Such a signature platform will characterize variability at multiple levels that go far beyond the demographics. A range of intrinsic and extrinsic factors linked to disease can now be utilized, including omics data sourced from proteome, metabolome, transcriptome, microbiome, epigenome, radiome, genome, and exposome databases.

Integrating such a molecular signature platform with other quantitative translation tools, advanced analytics, and bioelectronics will allow our industry to help detect disease risks earlier and better predict which therapy and dosage are best for the individual patient.

Merck, often working alongside leading academic groups and AI-driven start-ups, is also accelerating its use of advanced analytics and deep learning processes to discover and develop medicines. By integrating digital tools, we can extract hidden insights from massive datasets. This helps to predict potential compounds properties better and create novel solutions. Digital tools and data such as omics are also helping to improve the forward and reverse translation methods used to develop precision medicines efficiently.

A safe, accountable, and collaborative environment that facilitates more open and effective ecosystems will allow our industry to transform data into actionable insights and usher in a new era of precise and personalized patient care. Industry stakeholders must come together across each of these areas to ensure that the interests of patients are placed firmly at the centre of digital health.

Written by

Beln Garijo, Chair of the Executive Board and Chief Executive Officer, Merck

The views expressed in this article are those of the author alone and not the World Economic Forum.

See the article here:
Digital health is making healthcare more open, inclusive and patient-centred - World Economic Forum

Posted in Genetic Engineering | Comments Off on Digital health is making healthcare more open, inclusive and patient-centred – World Economic Forum

How Can We Reduce the MORTALITY due to CANCER – Mangalorean.com

Posted: at 6:28 am

Breast Cancer is among the most common cancers around the world. It is the most common cancer among women in India and around the world. Women in the North American continent have a 1 in 8 lifetime risk of getting cancer. In India Ratio is better, it is 1 in 28. Any cancer when detected early, is better treated. However, India is a densely populated nation. Breast cancer accounts for about 14 percent of cancer in women. Breast cancer mortality is 1.7 times higher than maternal mortality indicating the direness of the situation. Every 4 minutes, an Indian woman is diagnosed with cancer and every 13 minutes an Indian woman dies of cancer. The goal is to reduce mortality due to cancer.

HOW CAN WE DO IT?

1) Reduce the incidence: Less cancer, Lesser mortality.

2) Promote screening and early detection: Early cancers are better treated and have a good prognosis. Screening Mammogram has to be advocated in women with age > 40. Once in a year screening mammograms is very useful in a community.

Ignorance: Any lump can be cancerous. People have a very bad perception of cancer. They think cancer is painful to present with. Actually, it is the advanced stages that are more painful. People have to be told to present early. Lump in the breast, Skin changes in the breast, Recent retraction of nipple, Changes in the nipple-areolar complex are the early presentations that should be carefully evaluated.

Nihilism: Cancer is a word Not a Sentence summarises my thought. Diagnosing cancer doesnt mean the end of the world. Prognosis and treatment for cancer has evolved over the past decade. There are better treatments with even better results. There is a scientific way of seeing, diagnosing and treating cancer. When promptly done the treatment and prognosis does not vary much, no matter in which region the patient is getting treated. Surgery is the main mode of treatment of Breast cancer. Also important is the timing of the surgery and the proper use of adjuvant and neoadjuvant concepts. The use of chemotherapy and Radiation therapy is important when needed.

Modified Radical Mastectomy, popularly called MRM is the gold standard of surgery. It involves mastectomy (Removing the breast tissue completely) and axillary dissection (Removing the lymph nodes from the axilla, which are the next station of the spread of cancer). Then things have evolved over time. With the changes, patients suffering can be reduced. Lumpectomy (Removing the tumour ONLY with adequate margins) and Axillary dissection is the lesser surgery whenever possible. The breast is conserved and hence the name Breast Conservation Surgery. In this surgery, there are times when the contour of the breast is disturbed beyond cosmesis.

So recently we started concentrating on the aesthetics and rebuilding the breast architecture, hence called Breast Oncoplasty. Axillary dissection when done may lead to a long term complication of Limb Oedema due to Lymphoedema. This can happen in up to 20 percent of the people undergoing axillary dissection. Recently we have thought over this and scientifically formulated plans. Nowadays we do axillary dissection in patients only when axillary nodes are involved. In other patients after proper selection, we may avoid axillary dissection after Negative Sentinel Node Biopsy. A Sentinel node is a single or a group of nodes that are the first station of lymphatic flow. We can surgically identify this node, biopsy them and if negative aptly avoid an axillary dissection.

To summarise, the Breast is a superficial organ and we should not miss an opportunity to identify and diagnose early breast cancer. Screening has to be popularised among women. People should know and understand the easier modalities of treatment hence alleviating the treatment process. People should understand and take the benefit of better modalities of treatment.

Dr Karthik KS

Note: On the occasion of World Cancer Day, which was on 4 February with the theme: Close the Care Gap, this article is by Dr Karthik KS, Surgical Oncology, KMC hospital, Mangaluru

Like Loading...

Visit link:

How Can We Reduce the MORTALITY due to CANCER - Mangalorean.com

Posted in Nihilism | Comments Off on How Can We Reduce the MORTALITY due to CANCER – Mangalorean.com

Global Gene Editing Market Expected To Expand At Around 14.6% CAGR During 20202026 | Exclusive Report by Esticast Research The Grundy Register – The…

Posted: at 6:28 am

GET SAMPLE REPORTBUY COMPLETE REPORT

Esticast Research has published a new report titledGene Editing Market By Application (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering, and Others), By End-User (Contract Research Organization (CRO), Biotech & Pharma Companies, and Research Institutes), By Technology (Zinc Finger Nucleases (ZFNs), CRISPR/Cas9, TALENS, and Others), and By Region Global Industry Perspective, Comprehensive Analysis, and Forecast, 2020 2026.According to the report, Global Gene Editing Market Expected To Expand At Around 14.6% CAGR During 20202026.

The top Leading Market Players Covered in this Report are :Sangamo Therapeutics, Inc., Lonza Group, Integrated DNA Technologies, Editas Medicine, New England Biolabs, Horizon Discovery Group, Thermo Fisher Scientific, CRISPR Therapeutics, Merck KgaA, GenScript Corporation, and OriGene Technologies.

Download Free PDF Sample Reportwith Complete TOC and Figures & Graphs (withcovid 19Impact Analysis):https://www.esticastresearch.com/request-for-sample/?utm_source=PR&utm_medium=Gene-Editing-Market

Gene Editing Market analysis report is the representation of strategic research methodologies and market tactics. In order to fuel the business growth, knowing future scenario of the market and product sale is important and market research is the best way of obtaining forecasting of entire market scenario. Marketing strategy is also covered here to divide the market into different segments and target customers. Customers demands are also depicted in this Gene Editing Market report to aware industries and increase the productivity rate of products and services. It segments the market into different categories such as behavioral segmentations and demographic segmentation for the key regions such as North America, Europe, Middle East, Africa, Asia Pacific and Latin America..

Segments:

The primary market segments and their sub-segments covered in this study provide information on the overall business climate. The categories in this research are built by analyzing supply and demand scenario that provides a thorough view of the market. The segment study provides a detailed view of the fastest-growing market sector as well as the factors influencing the fast/slow growth of the other segments. This section includes a comprehensive market share and revenue analysis.

Geography

Esticast Research most recent market report is divided into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The report includes thorough financials for every region based on its segments. In addition, detailed revenue and market share analysis is given for major countries within every region.

GetExclusive Discount on this report: https://www.esticastresearch.com/inquiry-before-buying/?utm_source=PR&utm_medium=Gene-Editing-Market

In order to perform significant actions to lead business towards successful path, it is important to obtain all the market growth related data and nothing is better than referring Gene Editing Market survey report. It covers current market scenario and forecasting of upcoming market scenario for the period 2022-2028. This Gene Editing Market survey report signifies how trends will affect the entire business development and growth. It further makes available some profit making business opportunities to make the most out of it. It further does the key observation of the framework of the market within economy. Market trade statistics, key players, their adopted strategies, market share, leading suppliers, trade statistics and trend analysis are some of the key factors provided in this Gene Editing Market survey report to help business participants in making their business gainful and obtain best investment options.

Exact details regarding market performance is also provided in the Gene Editing Market analysis along with complete overview on competitive landscape, pricing structure, trend convergence, digital transformation, sales effectiveness, latest innovations, customer buying nature and pricing analysis. All these factors greatly contribute in enhancing the business growth and knowing the market performance. It becomes easy for central participants to track the business performance regularly with the help of this Gene Editing Market survey report. It talks about successful market strategies implemented by company players such as mergers, acquisitions, collaborations and novel item releases. It further aims at looking over all the compelling viewpoints from different major players, manufacturers to end buyer. Annual revenue, industry growth factors and market tactics are some of the significant factors covered in the Gene Editing Market research report. It also covers all the latest data regarding CORONA-19 virus effects on world economy. It further helps industry players to survive in the competitive market.

What Does This Report Provide?

This report provides a detailed understanding of the global Gene Editing Market from qualitative and quantitative perspectives during the forecast period. The major market drivers, challenges, and opportunities for the global Gene Editing Market have been covered in the report. This report further includes the market shares of the leading companies operating in the global market, along with their production capacities and the growth strategies adopted by them.

Inquiry Before Buying https://www.esticastresearch.com/get-discount/?utm_source=PR&utm_medium=Gene-Editing-Market

Objectives of this Report:

Key Questioned Answered in the Report:

Customization of the market analysis:

You can buy the complete report@https://www.esticastresearch.com/cart-share/nFzkB/?utm_source=PR&utm_medium=Gene-Editing-Market

Report includes Competitors Landscape:

Major trends and growth projections by region and countryKey winning strategies followed by the competitorsWho are the key competitors in this industry?What shall be the potential of this industry over the forecast tenure?What are the factors propelling the demand for theGene Editing Market ?What are the opportunities that shall aid in significant proliferation of the market growth?What are the regional and country wise regulations that shall either hamper or boost the demand for Gene Editing Market?How has the covid-19 impacted the growth of the market?Has the supply chain disruption caused changes in the entire value chain?

About Esticast Research:

Esticast Researchis a research firm providing research reports on various industries with a unique combination of authenticity, extensive research, and infallibility. We provide syndicated market research reports, customization services, and consulting services to help businesses across the world in achieving their goals and overcoming complex challenges. We specialize in providing 360-degree view of the markets to assist clients in determining new opportunities and develop business strategies for the future with data and statistics on changing market dynamics. Esticast Research & Consulting has expert analysts and consultants with an ability to work in collaboration with clients to meet their business needs and give opportunities to thrive in a competitive world. A comprehensive analysis of industries ranging from healthcare to consumer goods and ICT to BFSI is provided by covering hundreds of industry segments. The research reports offering market forecasts, market entry strategies, and customer intelligence will help clients across the world in harnessing maximum value on their investment and realize their optimum potential.

Contact:

Mr. Ashish GedamkarOffice No.407, Navale Icon IT Park+1-213-262-0704+91-959-503-5024sales@esticastresearch.comhttps://www.esticastresearch.com/

View post:
Global Gene Editing Market Expected To Expand At Around 14.6% CAGR During 20202026 | Exclusive Report by Esticast Research The Grundy Register - The...

Posted in Genetic Engineering | Comments Off on Global Gene Editing Market Expected To Expand At Around 14.6% CAGR During 20202026 | Exclusive Report by Esticast Research The Grundy Register – The…

Exclusive Research Report on Crispr And Crispr Associated Genes Market With Analysis of New Business Opportunities After Covid-19 Impact: Thermo…

Posted: at 6:28 am

Global Crispr And Crispr Associated Genes MarketResearch Report provides key analysis on the market status of the Crispr And Crispr Associated Genes with the best facts and figures, meaning, definition, SWOT analysis, expert opinions, and the latest developments across the globe. The report also calculates the market size, Sales, Price, Revenue, Gross Margin, Market Share, cost structure, and growth rate. The report considers the revenue generated from the sales of This Report and technologies by various application segments and Browse Market data Tables.

The Crispr And Crispr Associated Genes Market report covers the different market scenarios that have a direct impact on the growth of the market. The Crispr And Crispr Associated Genes report study includes information on market factors such as the market dynamics, including drivers, restraints, challenges, threats, potential growth opportunities, market trends, development patterns, financial information, latest technologies, innovations, leading competitors, and regional analysis of the market.

RequestMore Information on this Report (UseCorporate eMail ID to Get Higher Priority):https://www.worldwidemarketreports.com/sample/340162

Following Key Players are Mentioned in this Document:

Thermo Fisher Scientific Editas Medicine Caribou Biosciences CRISPR therapeutics Intellia therapeutics Inc. Cellectis Horizon Discovery Plc Sigma Aldrich Precision Biosciences Genscript Sangamo Biosciences Inc. Lonza Group Limited Integrated DNA Technologies New England Biolabs Origene Technologies

Analysis of Cardan ShaftMarket by Type

Genome Editing Genetic engineering GRNA Database/Gene Librar CRISPR Plasmid Human Stem Cells Genetically Modified Organisms/Crops Cell Line Engineering

Analysis of Cardan ShaftMarket by Application

Biotechnology Companies Pharmaceutical Companies Academic Institutes Research and Development Institutes

Get Sample to Understand More Details on Crispr And Crispr Associated Genes Market Segments:https://www.worldwidemarketreports.com/sample/340162

Regional Analysis for Crispr And Crispr Associated Genes Market:

North America (U.S., Canada)Europe (U.K., Italy, Germany, France, Rest of EU)Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)Latin America (Chile, Brazil, Argentina, Rest of Latin America)Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

(*NOTE: To get customization to your liking you can ADD / REMOVE Key Players, Regions, and any other Segments as you need.)

How Covid 19 Affected the Crispr And Crispr Associated Genes Market

Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Impact Crispr And Crispr Associated Genes market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations, travel bans, and quarantines, restaurants closed, all indoor/outdoor events restricted, over forty countries state of emergency declared, massive slowing of the supply chain, stock market volatility, falling business confidence, growing panic among the population, and uncertainty about future.

Get Specified Sample Containing COVID 19 Details:https://www.worldwidemarketreports.com/sample/340162

In this segment, we will give you the impact of COVID-19, how it affected the Crispr And Crispr Associated Genes market, and how it will change the industrys future depending on the current government, private, and public situations. Our expert analysts keep an open eye on every situation that may change the flow of the industry which will help you make the best possible decision for your enterprise.

The objective of the study is to define the Crispr And Crispr Associated Genes market sizes of different segments and countries in previous years and to forecast the values for the next five years. The report is designed to incorporate both qualified qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about crucial aspects such as drivers and restraining factors that will define the future growth of the Crispr And Crispr Associated Genes market.

You can Buy This Report Here:https://www.worldwidemarketreports.com/buy/340162

Report Coverage

Why Choose Crispr And Crispr Associated Genes Market Report?

Contact Us:

Worldwide Market Reports,Tel: U.S. +1-415-871-0703U.K. +44-203-289-4040Japan +81-50-5539-1737Email: [emailprotected]Website:https://www.worldwidemarketreports.com/

About WMR:

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provides our diverse range of clients from across all industries with vital decision-making insights to plan and align their market strategies in line with current market trends.

Read the original here:
Exclusive Research Report on Crispr And Crispr Associated Genes Market With Analysis of New Business Opportunities After Covid-19 Impact: Thermo...

Posted in Genetic Engineering | Comments Off on Exclusive Research Report on Crispr And Crispr Associated Genes Market With Analysis of New Business Opportunities After Covid-19 Impact: Thermo…